All Companies
print

Aleva Neurotherapeutics SA

Developing next-generation implants for Deep Brain Stimulation (DBS) therapy.

www.aleva-neuro.com


Alpex Pharma SA

Contract manufacturing and formulation of drugs and food supplements.

www.alpex.com

 

 

AM-Pharma BV

Developing alkaline phosphatase as treatment for severe inflammatory conditions

www.am-pharma.com

 

 

Anteis SA

Hyaluronic-based products for aesthetic medicine and other medical use (acquired by Merz Pharma).

www.anteis.com

 

 

Atlas Genetics Ltd

Developing point-of-care diagnostic devices

www.atlasgenetics.com

 

 

Cadence Pharmaceuticals, Inc.

Specialty therapeutics for hospitals (publicly listed, later acquired by Mallinckrodt) CADX)

www.mallinckrodt.com

 

 

Calypso Medical Technologies, Inc.

Tumor localisation systems (acquired by Varian)

www.varian.com

 

 

Cameron Health, Inc.

Subcutaneous implantable cardio defibrillators (acquired by Boston Scientific)

www.bostonscientific.com

 

 

Molecular Partners AG

Development of DARPIN based therapeutics (publicly listed: MOLN)

www.molecularpartners.com.

 

 

Neose Technologies, Inc.

Next generation biotherapeutics (asset sale to Teva and Novo Nordisk)

 

 

Natural Dental Implants AG

Minimally invasive dental implants for single tooth replacement

www.replicatetooth.com

 

 

Neoptics AG

Intracorneal lenses for the treatment of presbyopia

www.neoptics.ch

 

 

Optimer Pharmaceuticals, Inc.

Anti-infective therapeutics (publicly listed, later acquired by Cubist)

www.cubist.com

 

 

Opsona Therapeutics Ltd

Developing TLR agonists for the treatment of inflammatory conditions and cancer

www.opsona.com

 

 

Orthocon, Inc. (now Abyrx, Inc.)

Surgical biomaterials

http://www.abryx.com

 

 

Radius Health, Inc.

Developing therapeutics for osteoporosis and other serious endocrine mediated diseases (publicly listed: RDUS).

www.radiuspharm.com.

 

 

Sonetik AG

Hearing devices

www.sonetik.ch

 

 

Swiss Smile AG

Dental clinics chain

www.swiss-smile.ch

 

 

TargeGen, Inc.

Small molecule kinase inhibitors to treat cancer (acquired by Sanofi)

www.sanofi.com

 

 

Tioga Pharmaceuticals, Inc.

Developing therapeutics for the treatment of pruritus.

www.tiogapharma.com.

 

 

Vaximm AG

Developing cancer immuno-therapeutics

www.vaximm.com